Bone turnover in hyperthyroidism
3. Riggs B.L., Melton III L.J.
15. Moselkilde L., Eriksen, E.F., Charles P.
Involutional osteoporosis.
Effects of thyroid hormones on bone and mineral
metabolism.
N. Engl. J. Med. 1990, 314: 1676-1686.
Endocrinol. Metab. Clin. North Am. 1990, 19: 35-63.
4. Baran D.T., Braverman L.E.
Editorial: Thyroid hormones and bone mass.
J. Clin. Endocrinol. Metab. 1991, 72: 1182-1183.
16. Siddiqi A., Monson J.P., Wood F., Besser G.M.,
Burrin J.M.
Serum cytokines in thyrotoxicosis.
J. Clin. Endocrinol. Metab. 1999, 84: 435-439.
5. Grant D.J., Marion E.T., McMurdo M.E., Mole P.A.,
Paterson C.R.
Is previous hyperthyroidism still a risk factor for os-
teoporosis in post-menopausal women?
Clin. Endocrinol. 1995, 43: 339-345.
17. Siddiqi A., Burrin J.M., Wood D.F., Monson J.P.
T3 regulates the production of IL-6 and IL-8 in hu-
man bone marrow stromal and osteoblast-like cells.
J. Endocrinol. 1998, 157: 453-461.
6. Bauer D.C., Cummings S.R., Tao J.L., Browner W.S.,
SOFR Group.
18. Lee M.S., Kim K.Y., Lee M.C., Cho B.Y., Lee H.K.,
Koch C.S., Min H.K.
Hyperthyroidism increases the risk of hip fracture. A
prospective study.
J. Bone Miner. Res. 1992, 7: S121 (Abstract no. 166).
Negative correlation between the change in bone
mineral density and serum osteocalcin in patients
with hyperthyroidism.
7. Rosen C.J., Adler R.A.
J. Clin. Endocrinol. Metab. 1990, 70: 766-770.
Longitudinal changes in lumbar bone density in thy-
rotoxic patients after attainement of euthyroidism.
J. Clin. Endocrinol. Metab. 1992, 75: 1531-1534.
19. Mc.Leod J.M., Mc.Hardy K.C., Harvey R.D., Duncan
A., Reid I.W., Bewsher P.D., Robin S.P.
The early effects of radioiodine therapy for hyper-
thyroidism on biochemical indices of bone turnover.
Clin. Endocrinol. (Oxf.) 1993, 38: 49-53.
8. Lalau J.D., Sebert J.L., Marie A., Fournier A.,
Quichaud J.
Effect of thyreotoxicosis and its treatment on miner-
al and bone metabolism.
J. Endocrinol. Invest. 1996, 9: 491-496.
20. Rizzoli R., Poser J., Bargi U.
Nuclear thyroid hormone receptors in cultured bone
cells.
9. Siddiqi A., Burrin J.M., Nooan K., James I., Wood
D.F., Price C.P.
Metabolism 1986, 35: 71-74.
A longitudinal study of markers of bone turnover in
Graves’ disease and their value in predicting bone
mineral density.
21. Harvey R.D., Mc.Hardy K. C., Reid I.W.,Paterson F.,
Beusher P.D., Duncan A., Robins S.P.
Measurement of bone collagen degradation in hyper-
thyroidism and during thyroxine replacement therapy
using pyridinium cross-links as specific urinary markers.
J. Clin. Endocrinol. Metab. 1991, 72: 1189-1194.
J. Clin. Endocrinol. Metab. 1997, 82: 753-759.
10. Oikawa M., Kushida K., Takahashi M., Ohishi T.,
Hoshino H., Suzuki M., Ogihara H., Ishigaki J., Inoue T.
Bone turnover and cortical bone mineral density in the
distal radius in patients with hyperthyroidism being trea-
ted with antithyroid drugs for various periods of time.
Clin. Endocrinol. 1999, 50: 171-176.
22. Garnero P., Vassy B., Bertholin A., Riou J.P., Delmas P.D.
Markers of bone turnover in hyperthyroidism and the
effects of treatment.
J. Clin. Endocrinol. Metab. 1994, 78: 955-959.
11. Mundy G.R., Shapiro J.L., Baudelin J.C., Canalis E.
M., Raisz L.G.
23. Mosekilde L., Melsen F.
Effect of antithyroid treatment on calcium-phospho-
rus metabolism in hyperthyroidism. II: Bone histo-
morphometry.
Direct stimulation of bone resorption by thyroid
hormones.
J. Clin. Invest. 1976, 58: 529-534.
Acta Endocrinol. 1978, 87: 751-758.
12. Marcus R.
24. Minisola S., Pacitti M.T., Romagnoli E., Rosso R.,
Carnevale V., Caravella P., Scillitani A., Dicembrino F.
Clinical validation of a new immunoradiometric as-
say for intact human osteocalcin.
Cyclic nucleotide phosphodiesterase from bone:
characterization of the enzyme and studies of inhibi-
tion by thyroid hormones.
Endocrinology 1975, 96: 400-408.
Calcif. Tissue Int. 1999, 64: 365-469.
13. Mundy G.R., Luben R.A., Raisz L.G., Oppenheim J.J.,
Buell D.M.
25. Hannon R., Blumsohn A., Naylor K., Eastell R.
Response of biochemical markers of bone turnover
to hormone replacement therapy: impact of bio-
logical variability.
Bone resorbing activity in supernatants of lymphoid
cell lines.
N. Engl. J. Med. 1974, 290: 867-871.
J. Bone Miner. Res. 1998, 7: 1124-1132.
14. Gowen M., Wood D.D., Ihrie E.F., McGuire M.K.B.,
Russel G.G.
26. Jodar E., Munoz-Torres M., Escobar-Jimenez F.,
Quesada M., Luna J., Olea N.
An interleukin-like factor stimulates bone resorption
in vitro.
Nature 1983, 306: 378-380.
Antiresorptive therapy in hyperthyroid patients: lon-
gitudinal changes in bone and mineral metabolism.
J. Clin. Endocrinol. Metab. 1997, 82: 1989-1994.
731